View posters, abstracts and other materials about hemoglobinopathies presented at recent congresses.
The information on this page pertains to select congresses and congress materials. It is not intended to serve as a comprehensive overview of all congresses and congress materials. Please note that congress materials may include information about uses for which a product is not approved and/or information that is inconsistent with the product uses described in FDA-required labeling. Novo Nordisk does not suggest or recommend the use of its products in any manner other than as described in their FDA-required labeling. Please also note that all tables or figures derived from publications and presentations are copyright-protected works. You may not reproduce, prepare derivative works from, display or distribute these works unless you obtain the permission of the copyright owner, or as otherwise may be permitted by law.
Hemoglobinopathies | Website
European Hematology Association (EHA) 2026 Materials
Hemoglobinopathies | Website
SCDAA Annual National Convention (SCDAA 2025)
Hemoglobinopathies | Website
Global Sickle Cell Disease Network (GSCDN 2025)
Hemoglobinopathies | Website
The Foundation for Sickle Cell Disease (FSCDR) Materials
Hemoglobinopathies | Website
Annual Sickle Cell & Thalassaemia Conference (ASCAT)
Hemoglobinopathies | Website
American Society of Haematology (ASH) 2024 Materials
Hemoglobinopathies | Website
American Society of Haematology (ASH) Materials
Hemoglobinopathies | Website
European Hematology Association (EHA) 2025
International Society for Pharmacoeconomics and Outcomes Research
Academy of Managed Care Pharmacy
Disease Education
Publications
HCP-facing patient resources
Search the Medical Information Database
Novo Nordisk Medical is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Continuing education
Learn about accredited disease education opportunities supported by Novo Nordisk and provided by third-party organizations.